Telesis Bio (Convertible Preferred Stock)

Funding Details
Awarder
Inbox
Date Award
May 18, 2025
Vertical
Biotechnology
Funding URL
View Funding Page

Company Info
Company Description
Telesis Bio is a leading provider of DNA and mRNA synthesis solutions to accelerate therapeutic discovery with fast and flexible on-site automated foundries. The company empowers scientists to create novel, synthetic biology-enabled solutions for many of humanity's greatest challenges.
Market
Synthetic Biology
Location
San Diego, CA, USA
Coinvestors
Novalis LifeSciences, Northpond Ventures

Links
Back to Home Back to Biotechnology Deals View Funding Announcement